Manning & Napier Target 2010 I
Manning & Napier Fund, Inc290 Woodcliff DriveFairport, NY 14450
Map
Phone: 800-466-3863
| Category: | Target Date 2000-2010 | | Fund Family: | Manning & Napier | | Net Assets: | 48.70M | | Year-to-Date Return: | 2.57% | | Yield: | 2.28% | | Morningstar Rating: |  | | Fund Inception Date: | Mar 27, 2008 |
|
Brian W. Lester
Lead Manager since Dec 31, 2008 | | | Brian Lester is a Senior Analyst and the Managing Director of the Life Sciences Group at Manning & Napier. In this capacity, he is responsible for analyzing investment opportunities within the Life Sciences sector. In addition, Mr. Lester is a member of the Senior Research Group and an employee-owner. Prior to joining Manning & Napier in 1998, he worked as a Market Researcher for The Sutherland Group.
Mr. Lester earned his BS in Agriculture, Resource, and Managerial Economics from Cornell University and is a CFA charterholder. |
| Min Initial Investment: | 1,000,000 | | Min Initial Investment, IRA: | N/A | | Min Initial Investment, AIP: | 1,000,000 | | Min Subsequent Investment: | N/A | | Min Subsequent Investment, IRA: | N/A | | Min Subsequent Investment, AIP: | 25 |
|
| |
| The investment seeks to provide long-term capital growth and to moderate volatility consistent with its current asset allocation.
The fund seeks to achieve its investment objective by investing in a combination of underlying funds according to a target asset allocation strategy. These underlying funds will pursue asset allocation strategies, and will invest in a combination of stocks, bonds, and cash. It may invest to a limited extent directly in equity and fixed income securities and cash equivalents, including money market securities. |
| Last Dividend
(Dec 16, 2012)
:
| 0.17 | | Last Cap Gain
:
| 0.00 | | Annual Holdings Turnover
(May 15, 2013)
:
| 30.00% | | Average for Category: | 27.72% |
|
| Expense | MTHIX | Category Avg |
|---|
| Annual Report Expense Ratio (net): | 0.05% | 0.53% | | Prospectus Net Expense Ratio: | 0.82% | N/A | | Prospectus Gross Expense Ratio: | 1.09% | N/A | | Max 12b1 Fee: | N/A | N/A | | Max Front End Sales Load: | N/A | 5.03% | | Max Deferred Sales Load:
| N/A | 2.24% | | 3 Yr Expense Projection*: | 262 | 507 | | 5 Yr Expense Projection*: | 455 | 845 | | 10 Yr Expense Projection*: | 1,091 | 1,751 |
|
|
0.80%